WebJun 7, 2024 · On Monday, June 6, 2024, the Federal Trade Commission (FTC) voted unanimously to approve a “6(b)” study into the anti-competitive and abusive practices of Pharmacy Benefits Managers (PBMs), a move that has the potential to lead to significant relief for independent pharmacies and other providers that dispense drugs to patients. … WebJul 12, 2024 · This 6(b) study is not the first time the FTC has considered how certain PBM business practices may impact prescription drug costs. Almost two decades ago, …
Federal Trade Commission And Congress Want To Rein In PBMs - Forbes
WebJun 7, 2024 · NASP Provided Extensive Comments to the FTC on Anti-Competitive Market Practices Harmful to Non-Affiliated Specialty Pharmacy Businesses and the Specialty … WebJun 16, 2024 · The FTC’s leadership, a panel of five commissioners, voted unanimously to launch the investigation under section 6(b) of the Federal Trade Commission Act of 1914. The commissioners are a mix of two Democrats and two Republicans, with the fifth seat filled by the party that holds the White House. pure west compassion club holland mi
Cigna
WebApr 13, 2024 · The new plans from Cigna come amid close examination from regulators including the U.S. Federal Trade Commission which is conducting a study to see if rebates sought by pharmacy middlemen reduced competition, ultimately leading to higher drug prices. The PBM unit, Express Scripts, will also introduce a new co-pay plan for … WebSenator Grassley called on the FTC earlier this year to move forward on a revised 6(b) study to examine competitive concerns within the PBM industry. 13. This letter will provide a brief overview of the Committee’s investigative findings, explain how the business practices of PBMs influence list price especially in the insulin therapeutic class, WebJun 7, 2024 · WASHINGTON, D.C.—. The American Pharmacists Association (APhA) issued the following statement applauding the FTC’s announcement of a 5-0 vote to … section 83 children scotland act